[144] Innovative Eyewear, Inc. Series A Warrants 8/16/27 SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Innovative Eyewear, Inc. (ticker LUCYW) discloses a proposed sale of 760 common shares through Raymond James on 09/10/2025 on the NASDAQ with an aggregate market value of $1,611.20. The securities were acquired as an RSU grant on 08/19/2025 totaling 7,200 shares with payment in cash recorded on the same date. The filing also lists a prior sale by the reporting person of 2,225 shares on 08/19/2025 generating $4,422.00 in gross proceeds. The notice includes the standard representation that the seller does not possess undisclosed material information.

Positive

• Disclosure compliance: The filer provided required Rule 144 details, including broker, planned sale date, and acquisition history.
• Small size: The proposed sale of 760 shares represents a very small fraction (~0.017%) of the 4,574,600 shares outstanding, suggesting limited market impact.

Negative

• Insider selling: The reporting person completed a sale of 2,225 shares on 08/19/2025, which investors may view unfavorably despite its small size.

Insights

Securities Analyst

TL;DR: Routine Form 144 showing a small proposed sale from recent RSU grants; immaterial to market given outstanding shares.

The filing reports a proposed sale of 760 shares with an aggregate market value of $1,611.20. Given the issuer’s reported outstanding share count of 4,574,600, the proposed sale represents approximately 0.017% of outstanding shares, indicating negligible direct market impact. The seller previously sold 2,225 shares on 08/19/2025 for $4,422.00, consistent with routine monetization of recently vested RSUs. This is a standard disclosure under Rule 144 and does not itself indicate company-level operational changes.

Corporate Governance / Compliance Expert

TL;DR: Filing appears procedurally complete for a Rule 144 notification; disclosures include acquisition and recent sales details.

The notice specifies acquisition as an RSU grant dated 08/19/2025 and lists the broker and planned sale date and exchange. Inclusion of the prior sale in the three-month window and the signature attestation language aligns with regulatory requirements. There are no disclosed indications of undisclosed material information per the seller’s representation. From a compliance standpoint, the document provides the necessary transactional details for public record.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates 880 Carillon Parkway St. Petersburg FL 33716	760	1611.20	4574600	09/10/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/19/2025	RSU Grant	Issuer			7200	08/19/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
David Cohen 2566 NE 206th Ter Miami FL 33180	Common	08/19/2025	2225	4422.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for LUCYW disclose?

The Form 144 discloses a proposed sale of 760 common shares via Raymond James on 09/10/2025 on NASDAQ with an aggregate market value of $1,611.20.

How were the securities being sold acquired?

The securities were acquired as an RSU grant on 08/19/2025, with 7,200 shares recorded as acquired and payment noted as cash on that date.

Has the reporting person sold shares recently?

Yes. The filing lists a prior sale of 2,225 shares on 08/19/2025 that produced $4,422.00 in gross proceeds.

Who is the broker handling the proposed sale?

The broker named in the notice is Raymond James & Associates located at 880 Carillon Parkway, St. Petersburg, FL.

How material is this sale relative to outstanding shares?

The proposed sale of 760 shares represents approximately 0.017% of the reported 4,574,600 shares outstanding, indicating minimal direct market effect.